Skip to content

A dose-response study of norepinephrine for the treatment of post-spinal hypotension in patients with pregnancy-induced hypertension

A randomized double-blind dose-response study of a bolus infusion of norepinephrine in the treatment of post-spinal hypotension in patients with pregnancy-induced hypertension

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067890
Enrollment
Unknown
Registered
2023-01-30
Start date
2023-01-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension

Interventions

Group N1:norepinephrine 3 ug
Group N2:norepinephrine 4 ug
Group N3:norepinephrine 5 ug
Group N4:norepinephrine 6 ug
Group N5:norepinephrine 7 ug

Sponsors

Women's Hospital School of Medicine Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Single fetus PE patients who plan to perform elective cesarean section and choose combined spinal epidural anesthesia; 2. ASA grade II-III; 3. Aged 18-40 years; 4. Obtain ethical permission and informed consent of patients before the experiment; 5. The diagnostic criteria of preeclampsia are: blood pressure >= 140/90 mmhg, measurement interval at least 4 hours, 24-hour proteinuria >= 300 mg or test paper proteinuria >= 1+.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic hypertension, diabetes and serious cardiovascular and cerebrovascular diseases; 2. Patients with known fetal abnormalities or intrauterine growth restriction; 3. Patients with obstetric complications include premature rupture of membranes, placenta previa and placental abruption; 4. Those who have contraindications to intraspinal anesthesia or research related drugs; 5. The height is too high or too low (> 180 cm or < 150 cm); 6. Gestational age < 28 weeks.

Design outcomes

Primary

MeasureTime frame
Blood pressure;

Secondary

MeasureTime frame
Age;weight;height;Anesthesia induction-delivery time;Uterine incision-delivery time;

Countries

China

Contacts

Public ContactFeng Fu

Women's Hospital School of Medicine Zhejiang University

fufeng@zju.edu.cn+86 13588392113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026